Vermillion Investor Seeks Court Order to Force Company to Schedule Annual Shareholder Meeting | GenomeWeb

Vermillion shareholder George Bessenyei this week brought an action against the company in the Delaware Court of Chancery to force it to hold its annual shareholder meeting.

In the action, Bessenyei notes that Vermillion's last shareholder meeting was in June 2011 and asserts that the company is in violation of Section 211 of Delaware's General Corporation Law, which establishes the rules for corporate stockholder meetings.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.